Consolidated Investment Group LLC Emergent Bio Solutions Inc. Transaction History

Consolidated Investment Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 19, 2021	SELL	$79.17 - $111.47 $1.44 Million - $2.03 Million	-18,200 Closed	0 $0
Q2 2020 Jul 16, 2020	SELL	$54.33 - $89.52 $1.02 Million - $1.68 Million	-18,800 Reduced 50.81%	18,200 $1.44 Million
Q3 2019 Oct 21, 2019	SELL	$40.6 - $57.2 $1.14 Million - $1.6 Million	-28,000 Reduced 43.08%	37,000 $1.93 Million
Q1 2018 Apr 20, 2018	BUY	$44.44 - $54.39 $2.89 Million - $3.54 Million	65,000 New	65,000 $3.42 Million

154

30.2M

137K

706K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $377M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Consolidated Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Consolidated Investment Group LLC with notifications on news.